Open-label, Pivotal Clinical Trial to Confirm Efficacy and Safety of Autologous Grafts Containing Stem Cells Genetically Modified for Epidermis Restoration in Patients With Junctional Epidermolysis Bullosa
Stopped Development program review and update due to Sponsor re-organization
Conditions
- Junctional Epidermolysis Bullosa Non-Herlitz Type
Interventions
Sponsor
Holostem s.r.l.
Collaborators
- [object Object]
- [object Object]